Last reviewed · How we verify
NCT05994768: OEN
18F-FDG Tomography and Labeled Leukocyte Scintigraphy
trial testing 18F-FDG PET/CT in Malignant Otitis Externa in 18 participants. Completed in 18 October 2023.
12 July 2023
Quick facts
| Lead sponsor | Central Hospital, Nancy, France |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 18 |
| Start date | 18 December 2020 |
| Primary completion | 12 July 2023 |
| Estimated completion | 18 October 2023 |
| Sites | 1 location across France |
Drugs / interventions tested
- 18F-FDG PET/CT — full drug profile →
Conditions studied
- Malignant Otitis Externa — all drugs for Malignant Otitis Externa →
Sponsor
Central Hospital, Nancy, France
Who can join
Adults 18 to 80, any sex, with Malignant Otitis Externa. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study will aim to show that there is a superiority of 18F-FDG PET/CT compared to labeled leukocyte scintigraphy in patients with a malignant otitis externa.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05994768
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of 18F-FDG PET/CT
Trials testing the same drug.
- NCT07353554 — Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma · NA · not yet recruiting
- NCT06103838 — 18F-Fluciclovine PET/CT in Multiple Myeloma · Phase 2 · recruiting
- NCT06145399 — A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer · EARLY_PHASE1 · withdrawn
- NCT05730608 — 18F-FDG PET/CT Imaging for Breast Cancer · NA · recruiting
- NCT07430475 — Utility of 18F-FDG PET/CT for Suspected Infection in the Inpatient Setting: a Single Centre Retrospective Cohort Study · completed
Other Central Hospital, Nancy, France trials
Trials by the same sponsor.
- NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
- NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
- NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
- NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
- NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05994768 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
- Last refreshed: 30 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05994768.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing